Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing
Title: TLG Consulting Inc. - Comment
TLG Consulting Inc. - Comment
This is comment on Notice
Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing
View Comment
Attachments:
TLG Consulting Inc. - Comment
Title:
TLG Consulting Inc. - Comment
Related Comments
View AllPublic Submission Posted: 11/09/2010 ID: FDA-2010-N-0477-0003
Dec 31,2010 11:59 PM ET
Public Submission Posted: 11/09/2010 ID: FDA-2010-N-0477-0004
Dec 31,2010 11:59 PM ET
Public Submission Posted: 11/09/2010 ID: FDA-2010-N-0477-0009
Dec 31,2010 11:59 PM ET
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0477-0013
Dec 31,2010 11:59 PM ET
Public Submission Posted: 12/21/2010 ID: FDA-2010-N-0477-0014
Dec 31,2010 11:59 PM ET